昭衍新药
(603127)
| 流通市值：230.71亿 | | | 总市值：274.26亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-04-03 | 3297.30万 | 2.08% | -6435.71万 | -4.05% | 1937.40万 | 1.22% | 1201.01万 | 0.76% |
| 2026-04-02 | 945.91万 | 0.54% | -5511.61万 | -3.14% | 3567.99万 | 2.03% | 997.72万 | 0.57% |
| 2026-04-01 | 6503.41万 | 2.95% | 4175.83万 | 1.89% | 579.30万 | 0.26% | -11258.53万 | -5.10% |
| 2026-03-31 | 17561.02万 | 9.17% | 3501.06万 | 1.83% | -11293.08万 | -5.90% | -9769.00万 | -5.10% |
| 2026-03-30 | 6277.06万 | 4.28% | 1545.63万 | 1.05% | 7703.76万 | 5.25% | -15526.46万 | -10.58% |
| 2026-03-27 | 15609.72万 | 26.47% | 826.45万 | 1.40% | -6029.46万 | -10.23% | -10406.71万 | -17.65% |
| 2026-03-26 | -1261.06万 | -3.87% | -1065.00万 | -3.27% | -1273.34万 | -3.91% | 3599.41万 | 11.05% |
| 2026-03-25 | 516.22万 | 1.28% | 1114.46万 | 2.76% | 1610.66万 | 3.99% | -3241.34万 | -8.04% |
| 2026-03-24 | -4766.66万 | -9.31% | -693.90万 | -1.36% | -3470.03万 | -6.78% | 8930.60万 | 17.44% |
| 2026-03-23 | -2422.19万 | -4.87% | -3093.50万 | -6.22% | -5827.94万 | -11.71% | 11343.63万 | 22.80% |